We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRTN
201
DELISTED
Triton International Limited
TRTN
| $65.8M | 0.09% |
956,305
+383,391
| +67% | +$24.3M |
|
202
DXC Technology
DXC
$1.74B
| $65.5M | 0.09% |
2,470,844
+927,480
| +60% | +$25.8M |
|
203
Ambev
ABEV
$45.7B
| $65.4M | 0.09% |
24,026,051
+4,695,631
| +24% | +$13.7M |
|
204
Atkore
ATKR
$3.17B
| $64.9M | 0.09% |
571,822
+20,098
| +4% | +$2.1M |
|
205
Southwest Airlines
LUV
$22.2B
| $64.3M | 0.09% |
1,910,019
+951,984
| +99% | +$34.3M |
|
206
Regions Financial
RF
$26.8B
| $63.8M | 0.09% |
2,959,020
+1,528,502
| +107% | +$33.1M |
|
207
Agilent Technologies
A
$41.8B
| $62.7M | 0.09% |
419,158
+14,848
| +4% | +$2.12M |
|
208
United Parks & Resorts
PRKS
$2.07B
| $62.7M | 0.09% |
1,171,438
-6,976
| -0.6% | -$374K |
|
209
Ryder
R
$10B
| $62.1M | 0.09% |
743,446
-8,109
| -1% | -$681K |
|
210
Humana
HUM
$46.7B
| $62M | 0.09% |
121,145
+45,146
| +59% | +$23.7M |
|
211
Under Armour
UAA
$2.41B
| $61.8M | 0.09% |
6,084,024
+3,565,281
| +142% | +$30.8M |
|
212
Takeda Pharmaceutical
TAK
$56B
| $60.9M | 0.09% |
3,904,296
+2,465,178
| +171% | +$34.4M |
|
213
Penske Automotive Group
PAG
$14.2B
| $60.6M | 0.08% |
527,403
+96,845
| +22% | +$11M |
|
214
ICL Group
ICL
$6.96B
| $60M | 0.08% |
8,289,633
+1,129,708
| +16% | +$9.36M |
|
215
Jefferies Financial Group
JEF
$12.9B
| $57.2M | 0.08% |
1,746,057
+112,452
| +7% | +$3.74M |
|
216
Charter Communications
CHTR
$17.9B
| $57.1M | 0.08% |
168,379
-104,621
| -38% | -$36.8M |
|
217
Corpay
CPAY
$25.9B
| $56.4M | 0.08% |
306,801
+89,493
| +41% | +$16.4M |
|
218
ZIM Integrated Shipping Services
ZIM
$3.1B
| $55.1M | 0.08% |
3,206,542
-675,620
| -17% | -$15M |
|
219
Autodesk
ADSK
$53.6B
| $54.3M | 0.08% |
290,795
+42,303
| +17% | +$8.49M |
|
220
First Horizon
FHN
$12B
| $54.3M | 0.08% |
2,217,088
+26,834
| +1% | +$650K |
|
|
AAWW
221
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $54.3M | 0.08% |
538,488
+21,907
| +4% | +$2.2M |
|
222
Nice
NICE
$5.97B
| $54.2M | 0.08% |
281,992
-22,103
| -7% | -$4.26M |
|
223
H&R Block
HRB
$5.88B
| $53.7M | 0.08% |
1,471,892
+229,467
| +18% | +$9.33M |
|
224
Corteva
CTVA
$51.6B
| $53M | 0.07% |
901,458
-1,204,456
| -57% | -$76.2M |
|
225
Ingredion
INGR
$6.54B
| $52.8M | 0.07% |
539,572
+16,002
| +3% | +$1.48M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.